» Authors » Shufen Cui

Shufen Cui

Explore the profile of Shufen Cui including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 195
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao C, Cui S, Guan X, Chen Y, Zhang Y, Lin X, et al.
Plants (Basel) . 2024 Jun; 13(12). PMID: 38931018
Environmental changes induced by urbanization may significantly alter plant survival strategies, thereby introducing uncertainties in their ability to withstand extreme heat. This study, centered on Jinhua City, distinguished urban, suburban,...
2.
Chen Y, Yang Y, Zeng X, Feng J, Oakes K, Zhang X, et al.
J Chromatogr A . 2022 Oct; 1683:463520. PMID: 36209679
Although liposomes have demonstrated significant clinical success as drug delivery vehicles, pharmacokinetic (PK) profiling of liposomal nanomedicines remains difficult due to technical challenges accurately measuring low concentrations of free drug...
3.
Chen Y, Xian Y, Carrier A, Youden B, Servos M, Cui S, et al.
RSC Adv . 2022 May; 10(26):15541-15546. PMID: 35495428
Polymeric microneedles (MNs) are attractive transdermal drug delivery systems because of their efficient drug delivery and minimal invasiveness. Master template fabrication is the most time-consuming and costly step in producing...
4.
Shi Y, Huang J, Chen L, Wang S, Xu J, Zhu F, et al.
J Hazard Mater . 2021 Oct; 424(Pt B):127465. PMID: 34655872
Polycyclic aromatic hydrocarbons (PAHs), as a major source that significantly increase the risk of developing lung cancer, severely jeopardize public health in modern society. The analysis of PAHs and their...
5.
Singh P, Youden B, Yang Y, Chen Y, Carrier A, Cui S, et al.
ACS Appl Mater Interfaces . 2021 Aug; 13(35):41464-41472. PMID: 34448397
Multimodal nanotherapeutic cancer treatments are widely studied but are often limited by their costly and complex syntheses that are not easily scaled up. Herein, a simple formulation of glucose-oxidase-coated CuS...
6.
Shi Y, Huang S, Kuang Y, Chen Z, Guo J, Cui S, et al.
Anal Chim Acta . 2021 Apr; 1158:338422. PMID: 33863405
Solid phase microextraction (SPME) has potential to be used for the high-performance enrichments of hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs), which are important biomarkers of PAH exposure. By choosing suitable adsorbent,...
7.
Singh P, Zeng X, Chen X, Yang Y, Chen Y, Cui S, et al.
J Pharm Biomed Anal . 2020 Mar; 185:113230. PMID: 32169789
A rapid and sensitive liquid chromatography-tandem mass spectrometric method was developed and validated for the determination of HA15, an emerging anticancer compound targeting GSPA5/BIP delivered by dissolvable polymeric microneedles. The...
8.
Chen Y, Yang Y, Xian Y, Singh P, Feng J, Cui S, et al.
ACS Appl Mater Interfaces . 2019 Dec; 12(1):352-360. PMID: 31825580
Dissolvable polymeric microneedles (DPMNs) are promising transdermal drug delivery systems with minimal invasiveness and improved patient compliance. Incorporation of a small amount of graphene oxide (GO) in the biocompatible polymers...
9.
Singh P, Carrier A, Chen Y, Lin S, Wang J, Cui S, et al.
J Control Release . 2019 Oct; 315:97-113. PMID: 31644938
Polymeric microneedle (MN) systems are interesting transdermal drug delivery systems because of their controlled drug delivery, tunable properties, and ease of patient self-administration. They are biocompatible and can easily and...
10.
Chen Y, Wang W, Tyagi D, Carrier A, Cui S, He S, et al.
Nanoscale . 2019 Mar; 11(13):5879-5883. PMID: 30869719
Circulating tumor cells (CTCs) are indicative for cancer diagnosis and prognosis. However, conventional immuno-magnetic cell capture technologies using antibody- and aptamer-functionalized magnetic particles generate increased intracellular oxidative stress through endocytosis....